Back

Plenary II.

  • Published In: Transfusion Medicine, 2023, v. 33. P. 10 1 of 2

  • Database: Academic Search Ultimate 2 of 2

Abstract

Each contain 20,000 DNA probe s to form a "transfusion module" for HEA, HPA and HLA genotyping. PL II: BBTS AWARD LECTURES, RACE AND SANGER AWARD LECTURE 141 The blood transfusion genomics consortium: Implementation of at-scale donor and patient genot... Nicholas Gleadall 1 1 University of Cambridge, Cambridge, United Kingdom, 2 NHS Blood and Transplant, England, 3... B Background: b A universal blood donor and patient genotyping platform must be capable of accurately typing all clinically relevant Human Erythrocyte (HEA), Platelet (HPA), and Leukocyte (HLA) antigens. This worked case study illustrates the serological difficulties around ABO grouping following a massive transfusion, including an approach to solving the puzzle, how to report the results and which blood components to select for transfusion. [Extracted from the article]

Additional Information

  • Source:Transfusion Medicine. 2023/10, Vol. 33, p10
  • Document Type:Article
  • Subject Area:Health and Medicine
  • Publication Date:2023
  • ISSN:0958-7578
  • DOI:10.1111/tme.13001
  • Accession Number:172855611
  • Copyright Statement:Copyright of Transfusion Medicine is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Looking to go deeper into this topic? Look for more articles on EBSCOhost.